Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference


BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that Company management will participate in Citi’s 2024 Global Healthcare Conference, being held on December 3-5, in Miami, FL.

Read more:
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

Related Posts